VCM
KRRO icon

Versant Capital Management’s Korro Bio KRRO Stock Holding History

Versant Capital Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.1K Sell
539
-152
-22% -$1.89K ﹤0.01% 2346
2026
Q1 		$7.82K Buy
+691
New +$7.61K ﹤0.01% 2235
2025
Q4 		– Sell
-271
Closed -$13K – 2698
2025
Q3 		$13K Sell
271
-11
-4% -$244 ﹤0.01% 1818
2025
Q2 		$3.52K Buy
+282
New +$4.06K ﹤0.01% 2272

Other funds holding KRRO

Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
NSIM
North Star Investment Management Chicago, Illinois $1.84B AUM 28.81% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
TWC
TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return
EWA
EverSource Wealth Advisors Birmingham, Alabama $2.97B AUM 28.74% 1-Year Est. Return
DSC
Duncker Streett & Co St. Louis, Missouri $591M AUM 26.48% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Versant Capital Management's KRRO Position: Q2 2026 in Review

Versant Capital Management reduced its Korro Bio (KRRO) stake by 22% in Q2 2026, selling an estimated $1.89K and leaving 539 shares worth $7.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2346.

Versant Capital Management first reported a position in KRRO in Q2 2025 and has held it in 4 quarters since. The position peaked at $13K in Q3 2025. 17 funds tracked by Wall St. Rank hold KRRO as of Q2 2026.

  • Versant Capital Management held 539 shares of Korro Bio worth $7.1K as of Q2 2026.
  • Versant Capital Management sold 152 Korro Bio shares in Q2 2026, an estimated $1.89K.
  • Korro Bio made up ﹤0.01% of Versant Capital Management's portfolio in Q2 2026, its #2346 holding.
  • Versant Capital Management first reported a position in Korro Bio in Q2 2025 and has held it in 4 quarters since.
  • Versant Capital Management's Korro Bio position peaked at $13K in Q3 2025.
  • 17 funds tracked by Wall St. Rank held Korro Bio as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.